Application of Tumor Treating Fields (TTFields) to open the blood brain barrier (BBB) as future CNS drug delivery strategy

• E. Salvador,
• A.F. Kessler,
• A. Giniunaite,
• M. Burek,
• C. Tempel Brami,
• T. Voloshin,
• M. Giladi,
• R.-I. Ernestus,
• M. Löhr,
• C. Förster,
• C. Hagemann

Affiliations

E. Salvador

University of Würzburg, Department of Neurosurgery, Tumorbiology Laboratory, Würzburg, Germany

A.F. Kessler

University of Würzburg, Department of Neurosurgery, Tumorbiology Laboratory, Würzburg, Germany

A. Giniunaite

University of Würzburg, Department of Neurosurgery, Tumorbiology Laboratory, Würzburg, Germany; Klinikum Aschaffenburg-Alzenau, Neurosurgery, Aschaffenburg, Germany

M. Burek

University of Würzburg, Department of Anesthesia and Critical Care, Division Molecular Medicine, Würzburg, Germany

C. Tempel Brami

Novocure Ltd., Haifa, Israel

T. Voloshin

Novocure Ltd., Haifa, Israel

M. Giladi

Novocure Ltd., Haifa, Israel

R.-I. Ernestus

University of Würzburg, Department of Neurosurgery, Tumorbiology Laboratory, Würzburg, Germany

M. Löhr

University of Würzburg, Department of Neurosurgery, Tumorbiology Laboratory, Würzburg, Germany

C. Förster

University of Würzburg, Department of Anesthesia and Critical Care, Division Molecular Medicine, Würzburg, Germany

C. Hagemann

University of Würzburg, Department of Neurosurgery, Tumorbiology Laboratory, Würzburg, Germany